TY - JOUR
T1 - Case Report
T2 - Extensive Facial Cutaneous Leishmaniasis in a Neonate
AU - Gabay, Sapir Itzhaki
AU - Valdman-Grinshpoun, Yuliya
AU - Ling, Galina
AU - Ben-Shimol, Shalom
AU - Test, Gidon
AU - Kaplan, Or
AU - Horev, Amir
N1 - Publisher Copyright:
Copyright © 2023 American Society of Tropical Medicine and Hygiene.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Cutaneous leishmaniasis (CL) is a skin infection caused by various species of the Leishmania parasite and is spread by the bite of an infected female sandfly. In southern Israel, CL caused by Leishmania major is endemic. Cutaneous leishmaniasis is considered a self-limiting disease, characterized by progressive, long-lasting nodulo-ulcerative skin lesions, which usually resolve in several months to years, and leads to scarring, cosmetic disfigurement, and future stigmatization. Although CL is a common disease among children, reports of CL in children younger than 1 year are rare. We present a case of extensive facial CL in an infant whose initial lesions appeared only 25 days after birth. The patient was treated with intravenous liposomal amphotericin B. Two months later, marked improvement was seen, with complete resolution of the inflammation and atrophic scar formation. To our knowledge, this is the earliest age of CL published to date.
AB - Cutaneous leishmaniasis (CL) is a skin infection caused by various species of the Leishmania parasite and is spread by the bite of an infected female sandfly. In southern Israel, CL caused by Leishmania major is endemic. Cutaneous leishmaniasis is considered a self-limiting disease, characterized by progressive, long-lasting nodulo-ulcerative skin lesions, which usually resolve in several months to years, and leads to scarring, cosmetic disfigurement, and future stigmatization. Although CL is a common disease among children, reports of CL in children younger than 1 year are rare. We present a case of extensive facial CL in an infant whose initial lesions appeared only 25 days after birth. The patient was treated with intravenous liposomal amphotericin B. Two months later, marked improvement was seen, with complete resolution of the inflammation and atrophic scar formation. To our knowledge, this is the earliest age of CL published to date.
UR - http://www.scopus.com/inward/record.url?scp=85170110535&partnerID=8YFLogxK
U2 - 10.4269/ajtmh.23-0177
DO - 10.4269/ajtmh.23-0177
M3 - Article
C2 - 37487561
AN - SCOPUS:85170110535
SN - 0002-9637
VL - 109
SP - 624
EP - 625
JO - American Journal of Tropical Medicine and Hygiene
JF - American Journal of Tropical Medicine and Hygiene
IS - 3
ER -